Keybanc Upgrades Avid Bioservices to Overweight, Announces $20 Price Target
Keybanc analyst Paul Knight upgrades Avid Bioservices (NASDAQ:CDMO) from Sector Weight to Overweight and announces $20 price target.
Alembic Global Upgrades Methanex to Overweight, Announces $60 Price Target
Alembic Global analyst Hassan Ahmed upgrades Methanex (NASDAQ:MEOH) from Neutral to Overweight and announces $60 price target.
DA Davidson Upgrades Joint to Neutral, Raises Price Target to $15
DA Davidson analyst Linda Bolton Weiser upgrades Joint (NASDAQ:JYNT) from Underperform to Neutral and raises the price target from $12 to $15.
Baird Upgrades Truist Finl to Outperform, Announces $53 Price Target
Baird analyst David George upgrades Truist Finl (NYSE:TFC) from Neutral to Outperform and announces $53 price target.
TD Cowen Upgrades Moderna to Outperform, Raises Price Target to $180
TD Cowen analyst Tyler Van Buren upgrades Moderna (NASDAQ:MRNA) from Market Perform to Outperform and raises the price target from $150 to $180.
Citigroup Upgrades Charles Schwab to Buy, Lowers Price Target to $75
Citigroup analyst Chris Allen upgrades Charles Schwab (NYSE:SCHW) from Neutral to Buy and lowers the price target from $83 to $75.
Wells Fargo Upgrades Eli Lilly to Overweight, Raises Price Target to $375
Wells Fargo analyst Mohit Bansal upgrades Eli Lilly (NYSE:LLY) from Equal-Weight to Overweight and raises the price target from $360 to $375.
Wells Fargo Upgrades JPMorgan Chase to Overweight, Raises Price Target to $155
Wells Fargo analyst Mike Mayo upgrades JPMorgan Chase (NYSE:JPM) from Equal-Weight to Overweight and raises the price target from $148 to $155.
Keefe, Bruyette & Woods Upgrades Truist Finl to Market Perform, Lowers Price Target to $45
Keefe, Bruyette & Woods analyst David Konrad upgrades Truist Finl (NYSE:TFC) from Underperform to Market Perform and lowers the price target from $47 to $45.
A Bull Case For Marathon Petroleum As Margins For Refining Become More Profitable
Oil refining and transportation company Marathon Petroleum Corp (NYSE:MPC) received positive analysis from Mizuho securities analysts looking at…